William R Jacobs

Title: William R Jacobs: Innovator in Monoclonal Antibodies and Genetic Engineering

Introduction

William R Jacobs is a notable inventor based in the Bronx, NY (US). He has made significant contributions to the fields of medicine and genetic engineering, holding a total of 2 patents. His work primarily focuses on the development of monoclonal antibodies and genetically modified cell lines.

Latest Patents

Jacobs' latest patents include groundbreaking innovations. The first patent involves monoclonal antibodies for the prevention and treatment of herpes simplex viral infections. This patent provides antibodies and antigen-binding fragments that specifically bind to herpes simplex virus-2 (HSV-2), along with methods of use and pharmaceutical compositions that incorporate these antibodies. The second patent pertains to a genetically modified mammalian cell and cell line, which includes a recombination sequence inserted into a target locus on a chromosome of the mammalian cell genome. This invention features a transgenic mammalian cell and cell line that integrates a heterologous nucleic acid stably, allowing for the expression of a heterologous gene.

Career Highlights

Throughout his career, Jacobs has worked with prestigious institutions such as the Albert Einstein College of Medicine and Duke University. His research has significantly advanced the understanding and treatment of viral infections, showcasing his commitment to improving public health through innovation.

Collaborations

Jacobs has collaborated with notable colleagues, including Lawrence Leung and Regy Lukose. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

William R Jacobs stands out as an influential inventor in the fields of monoclonal antibodies and genetic engineering. His contributions have the potential to impact medical treatments significantly.